Full Breakdown
India-US Trade Talks: Goyal’s US Visit Amid Shifting Tariff Regime and New Russia Sanctions Law
By Drooid · · How we work
Core Event – Goyal-Greer Talks Target a Preferential Tariff Edge
Commerce and Industry Minister Piyush Goyal travelled to the United States from September 29 to October 5, 2026. The trip coincided with the G20 Trade Ministers’ meeting in Milwaukee on September 30 and October 1, 2026 and included bilateral talks with U.S. Trade Representative Jamieson Greer aimed at finalising an interim India-U.S. Bilateral Trade Agreement (BTA). India’s primary objective is to secure a tariff rate lower than those applied to rivals such as Vietnam, Bangladesh, Thailand, Cambodia, Indonesia, Malaysia and Sri Lanka.
Background & Context – February Framework and Subsequent U.S. Policy Shifts
The negotiations rest on the February 7, 2026 joint statement, which set an 18 percent reciprocal tariff on most Indian goods and called for India to reduce or eliminate tariffs on U.S. industrial and agricultural products. That framework was altered by several U.S. developments:
- The U.S. Supreme Court’s February 20 ruling that the International Emergency Economic Powers Act could not be used to impose reciprocal tariffs, prompting a shift to Section 122 (expired July 24) and Section 301 authorities.
- A Section 301 investigation added a 10 percent duty on Indian imports for forced-labour concerns, lower than the 12.5 percent rate initially proposed.
- Separate Section 232 tariffs continue at 50 percent on steel and aluminium.
- The Lindsey O. Graham Sanctioning Russia and Iran Act of 2026, signed by President Donald Trump on September 18, authorises tariffs of up to 100 percent on countries that purchase Russian oil or gas. India, a major buyer of Russian crude, faces uncertainty about future duties.
Data & Statistics – Trade Flows and Tariff Figures
- India’s exports to the United States rose 21.83 percent year-on-year to $8.4 billion in August 2026; imports from the United States increased 65.78 percent to $5.97 billion.
- In the first four months of FY 2027, India posted a merchandise trade surplus of about $12.4 billion with the United States, up from $15.4 billion a year earlier.
- Overall U.S. imports of Indian goods grew 22.4 percent to $22.12 billion, while U.S. exports to India rose 6.17 percent to $42.8 billion (April-August 2026-27).
Verbatim Quotes
- “As soon as the US is able to give us the preferential rate in comparison to our competition, we will finalise the BTA and announce the final details,” — Piyush Goyal, industry minister
Conflicting Reports & Gaps – Uncertainty Over Future Russia-Linked Tariffs
Analysts cannot determine whether the interim BTA’s effective duty on Indian goods will rise beyond the current 10 percent Section 301 rate. The U.S. plan to raise tariffs on generic drugs to 100 percent from August 2028 and 200 percent from August 2029 leaves open whether Indian exporters of pharmaceutical ingredients will face higher barriers, as exemptions for certain specialty drugs remain “subject to change.”
What’s Next – Upcoming Milestones
- September 30 and October 1, 2026 – G20 Trade Ministers’ meeting, where India will advocate a rules-based multilateral trading system.
- Completion of the interim BTA remains contingent on the United States providing the preferential tariff rate sought by India.
- Ongoing U.S. legislative monitoring of the Russia sanctions law and Section 301 investigations will shape the final duty structure for Indian exports.
The outcome of Goyal’s discussions with Greer will determine whether India secures the competitive tariff edge it seeks, or whether additional U.S. duties linked to Russian crude purchases alter the calculus of the bilateral trade relationship.
